View in EDS HTML Full Text PDF Full Text

Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters.

Saved in:
Bibliographic Details
Title: Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters.
Authors: Stark, Felicity C.1 (AUTHOR), Akache, Bassel1 (AUTHOR) Bassel.akache@nrc-cnrc.gc.ca, Deschatelets, Lise1 (AUTHOR), Tran, Anh1 (AUTHOR), Stuible, Matthew1 (AUTHOR), Durocher, Yves1 (AUTHOR), McCluskie, Michael J.1 (AUTHOR), Agbayani, Gerard1 (AUTHOR), Dudani, Renu1 (AUTHOR), Harrison, Blair A.1 (AUTHOR), Renner, Tyler M.1 (AUTHOR), Makinen, Shawn R.1 (AUTHOR), Bavananthasivam, Jegarubee1 (AUTHOR), Duque, Diana1 (AUTHOR), Gagne, Martin2 (AUTHOR), Zimmermann, Joseph3 (AUTHOR), Zarley, C. David4,5 (AUTHOR), Cochrane, Terrence R.4,6 (AUTHOR), Handfield, Martin4 (AUTHOR)
Source: Scientific Reports. 6/13/2022, Vol. 12 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-022-13819-5